CRI Names Newest Class of STARs Six U.S. scientists have been awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer... junio 22, 2022octubre 10, 2022
Cellular Cancer Immunotherapy Therapy Landscape Update Latest analysis from the Cancer Research Institute of the global landscape of cellular immunotherapies, including R&D trends... junio 1, 2022octubre 25, 2022
10th Annual Cancer Immunotherapy Month™ Awareness and educational program offerings for cancer patients and caregivers about the latest advances in cancer immunotherapy... mayo 27, 2022octubre 14, 2022
First Patients in Ovarian Cancer Trial First patients dosed in phase 2 platform clinical trial testing novel immunotherapy combinations in highly malignant ovarian... mayo 11, 2022julio 13, 2022
PD1/PDL1 Immuno-Oncology Landscape Trends CRI’s latest analysis of the PD1/PDL1 immuno-oncology landscape confirms trends in trial design and patient enrollment, points... febrero 10, 2022octubre 12, 2022
mRNA Vaccine Creators to Receive 2021 William B. Coley Award Four Key Scientists Behind the Vaccines to Share Virtual Stage at November 10 Event; Katalin Karikó, Ugur... noviembre 4, 2021octubre 12, 2022
